General

Dupuytren and Worker Compensation
By: Charles Eaton
Apr 6, 2016

Is Dupuytren disease work related? If so, how should workers be compensated? This issue has been discussed since the 1800s along with legal and financial implications. This article is an example:  http://www.thenational.scot/news/dwp-accused-of-denying-industrial-benefits-to-workers.15966. It’s not a simple issue. The major risk for developing Dupuytren disease is believed to be genetic. Trauma and exposure to high manual stresses […]

Read more ›
First Dupuytren Nodule

My first Dupuytren palm nodule. What will to happen to me? Most Dupuytren disease starts as a nodule. Some nodules go away without any treatment. Some nodules develop minor cords and then seem to stop. Some nodules are the first sign of severe Dupuytren disease. Which is it going to be? Without a biomarker, we can […]

Read more ›
Dupuytren Contracture Procedure Choice
Dupuytren Contracture Procedure Choices

If a hand progresses from early Dupuytren disease (nodules, dimples, cords with no limitation of motion) to Dupuytren contracture, treatment should be considered.  The best compromise between the ordeal of a procedure and the best long term outcome is to treat either when the finger is either awkwardly bent or if the bend of one joint […]

Read more ›
Contracture or Disease?
Dupuytren Disease versus Dupuytren Contracture
On: Dec 11, 2015
By: Charles Eaton

What is the difference between Dupuytren Disease and Dupuytren Contracture? Dupuytren Disease is condition in which there is an imbalance in the body’s ability to regulate part of the biology involved in healing and scarring. The medical name for the changes caused by Dupuytren disease is fibrosis: tough, scar like tissue forms where it doesn’t belong. […]

Read more ›
Biomarkers in Dupuytren Disease
IDDB, biomarkers and big data to cure Dupuytren disease
On: Dec 9, 2015
By: Charles Eaton

The International Dupuytren Data Bank (IDDB) will focus on Dupuytren biomarkers Why are biomarkers important for Dupuytren disease? Dupuytren contracture is an effect, not a cause. Think of fever. Fever is an effect of infection, drug reaction, or something else. Just treating the effect – the fever – doesn’t cure the cause. ‌‌ You have to find […]

Read more ›
GivingTuesday Deal for the Dupuytren Foundation
On: Dec 1, 2015
By: Charles Eaton

It has been a great year – thanks to you! We’ve launched the International Dupuytren Data Bank (IDDB) – research for a cure, to be the largest Dupuytren study in history. Now that the IDDB is underway, your support is more important than ever. Please consider increasing your year-end gift to the Dupuytren Foundation this year […]

Read more ›
Three types of Dupuytren disease?

It’s important to understand the difference between Dupuytren disease (any Dupuytren like changes in the hand – with or without contracture) and Dupuytren contracture (a bent finger due to Dupuytren like changes). An unsolved issue is variability of disease. It is not known what percent of people with early Dupuytren changes (a lump, a cord without contracture) will […]

Read more ›
Options For Severe Dupuytren Recontracture 2/2

The three traditional treatments for severe recurrent Dupuytren contracture are PIP joint fusion, dermofasciectomy and amputation. These have been reviewed here. The list of alternative approaches is growing, particularly for the most difficult problem of PIP joint recontracture. The problem is that over time, the tendons and ligaments of a bent PIP joint change and […]

Read more ›
Will Winford’s Dupuytren Challenge: Climbing El Capitán for a Cure

Dupuytren disease is a challenge. So is climbing straight up the side of a tall mountain with your bare hands. Today Will Winford, a 27 year old rock climber with Dupuytren disease, begins his conquest of both – climbing  the 3000 vertical feet of El Capitán and using this to help raise awareness of Dupuytren disease. Find […]

Read more ›
The Knowledge Gap
On: Jul 29, 2015
By: Charles Eaton

Dupuytren disease has fallen through a gap in a system which ordinarily leads to better and better disease treatment. One side of the gap is that at its core, Dupuytren disease is a medical disorder, from some subtle biologic imbalance. The other side is that although Dupuytren disease does many things, Dupuytren hand deformity has […]

Read more ›